[ad_1]
By Richard Pagliaro | @Tennis_Now | Thursday, November 14, 2024
Photograph credit score: Flaviu Buboi/Nur Images/Getty
Nikola Bartunkova can return to tennis now.
The 2023 Wimbledon ladies’ finalist accepted a six-month suspension after testing optimistic for the banned substance trimetazidine in February and March.
More: TC Suspends Jon Wertheim
The International Tennis Integrity Agency introduced at present the Czech participant bore “no vital fault or negligence” for the unintentional anti-doping violation. Bartunkova turned eligible to return to tennis on November eleventh.
The 18-year-old Bartunkova reached a career-high singles rating of No. 226 in April 2024.
Following an investigation, the ITIA accepted that the optimistic exams for trimetazidine have been “attributable to the contamination of a complement containing milk thistle extract, that the violation was not intentional, and that the participant bore no vital fault or negligence,” the ITIA mentioned in a press release.
After investigation, Bartunkova instructed the ITIA on October twenty seventh {that a} contaminated complement was the supply of the trimetazidine present in her pattern.
In response, the ITIA instructed the impartial and WADA-accredited Sports activities Medication Analysis & Testing Laboratory (SMRTL) in Utah, USA, to check the complement. These findings have been confirmed, and the state of affairs was verified by an impartial scientific professional as believable.
Following an interview with Bartunkova, the ITIA accepted that the violation was not intentional and that the she bore “No Important Fault or Negligence” for the anti-doping violation.
The Czech teenager is at the moment ranked No. 488 and has earned $84,031 in profession prize cash.
[ad_2]
Source link
